Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine

Chronic pain syndromes present a subversion of both functional and structural nociceptive networks. We used transcranial magnetic stimulation (TMS) to evaluate changes in cortical excitability and plasticity in patients with chronic migraine (CM) treated with botulinum neurotoxin type A (BoNT/A). We...

Full description

Bibliographic Details
Main Authors:	Mariarosaria Valente, Christian Lettieri, Valentina Russo, Francesco Janes, Gian Luigi Gigli
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Toxins
Subjects:	chronic pain transcranial magnetic stimulation chronic headache migraine
Online Access:	https://www.mdpi.com/2072-6651/13/6/392

Similar Items

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01)

Potential mechanisms supporting the value of motor cortex stimulation to treat chronic pain syndromes
by: Marcos Fabio DosSantos, et al.
Published: (2016-02-01)

Effect of botulinum toxin on improving quality of life in patients with chronic migraine
by: Magdalena Marzęda, et al.
Published: (2022-09-01)

Risks of suicide in migraine, non-migraine headache, back, and neck pain: a systematic review and meta-analysis
by: Alec Giakas, et al.
Published: (2023-04-01)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
by: Carlo Baraldi, et al.
Published: (2023-01-01)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
by: Katarzyna Kępczyńska, et al.
Published: (2022-09-01)

Clinical features of episodic migraine and transformed migraine: a comparative study
by: José Carlos Busto Galego, et al.
Published: (2002-12-01)

Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
by: Antonio Santoro, et al.
Published: (2019-11-01)

Stem Cells in the Treatment of Refractory Chronic Migraines
by: Alexander Mauskop, et al.
Published: (2017-06-01)

Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials)
by: Jessica Ailani, et al.
Published: (2020-10-01)

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
by: Ivan Urits, et al.
Published: (2020-03-01)

An Evidence-Based Review of Galcanezumab for the Treatment of Migraine
by: Ivan Urits, et al.
Published: (2020-10-01)

Results of treating Patients with Chronic Migraine with OnabotulinumtoxinA alone Versus Its Combination with Other Prophylactic Drugs
by: Saber Abdelrohman, et al.
Published: (2022-04-01)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
by: Ioana Ion, et al.
Published: (2018-06-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
by: Jennifer Robblee
Published: (2023-09-01)

Patient self rated pain: headache versus migraine a retrospective chart review
by: Elizabeth Toigo, et al.
Published: (2024-10-01)

Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
by: Gibler RC, et al.
Published: (2022-09-01)

Botulinum Therapy for Chronic Migraine
by: Chumpol Anamnart, et al.
Published: (2020-04-01)

The Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) versus Transcranial Direct-Current Stimulation (tDCS) on Migraine Headaches: A Randomized Clinical Trial
by: Fatemeh Naji, et al.
Published: (2024-01-01)

Migraine and cluster headache show impaired neurosteroids patterns
by: Angela Koverech, et al.
Published: (2019-05-01)

Autism and Migraine: An Unexplored Association?
by: Luigi Vetri
Published: (2020-09-01)

Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis
by: J.O. Lloyd, et al.
Published: (2022-06-01)

Neurobiology of migraine progression
by: Wanakorn Rattanawong, et al.
Published: (2022-08-01)

Transient Receptor Potential Channels and Botulinum Neurotoxins in Chronic Pain
by: Eun Jin Go, et al.
Published: (2021-10-01)

COMPARATIVE CLINICAL ELECTRONEUROPHYSIOLOGICAL CHARACTERISTICS OF CHRONIC MIGRAINE
by: A. A. Yakupova, et al.
Published: (2017-12-01)

Degradation of endocannabinoids in chronic migraine and medication overuse headache
by: L.M. Cupini, et al.
Published: (2008-05-01)

Response to treatment with Botulinum toxin-A in patients with Refractory Chronic Migraine
by: Amir Molaei, et al.
Published: (2024-10-01)

Muscle tenderness and psychiatric comorbidity: a vicious cycle in migraine chronicization.
by: Eugenia eRota, et al.
Published: (2014-08-01)

Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention
by: Sebastian Worsaae Dalby, et al.
Published: (2024-02-01)

Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study
by: Valentina Rebecchi, et al.
Published: (2021-05-01)

Editorial: Women in science: headache
by: Danielle D. DeSouza, et al.
Published: (2023-11-01)

Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers
by: Cristina Tassorelli, et al.
Published: (2017-06-01)

Long-term prophylactic efficacy of transcranial direct current stimulation in chronic migraine. A randomised, patient-assessor blinded, sham-controlled trial
by: Hasan Hodaj, et al.
Published: (2022-03-01)

A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine
by: Kwok YH, et al.
Published: (2016-10-01)

Catastrophization is related to the patient and not to the severity of migraine
by: Eduardo Almeida Guimarães Nogueira, et al.
Published: (2021-09-01)

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
by: Hans-Christoph Diener, et al.
Published: (2022-05-01)

Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study
by: Hida Nierenburg, et al.
Published: (2020-07-01)

Nummular headache: a case report of remission following ketogenic diet and botulinum toxin type A injections
by: Yan Tereshko, et al.
Published: (2023-05-01)

OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
by: Ali Zandieh, et al.
Published: (2022-06-01)